Curcumin is a low‐cost and easily accessible therapeutic option for COVID‐19 patients. We aimed to conduct a meta‐analysis to assess the effect of curcumin on clinical outcomes in …
Background The COVID-19 pandemic continues, and this condition has caused many cases in various countries around the world, resulting in more than 6 million deaths worldwide …
N Bulatova, S Younes, M Arabiyat, A Abukaff… - Plos one, 2022 - journals.plos.org
Introduction There is inadequate evidence to recommend the use of any traditional and complementary medicine (T&CM) methods such as vitamin, mineral, herbal or other dietary …
Introduction In hospitalised mild to moderate COVID-19 patients with pre-existing type 2 diabetes, we evaluated the efficacy of add-on customised Ayurveda intervention as …
S Kumar, K Ramaraju, MS Kakarla, SS Eranezhath… - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Background Effective management of both acute and post-acute sequelae of SARS-CoV-2 is essential, particularly for type 2 diabetes mellitus (T2DM) patients, who are at increased …
P Tyagi, K Jain, IV Basavaraddi - Indian Journal of Physical …, 2024 - journals.lww.com
The COVID-19 pandemic had an immense impact on the world, affecting millions of people and prompting medical professionals to work tirelessly to save lives. In addition to …
BK Khuntia, A Agarwal, G Sharma - Complementary Therapies in …, 2022 - ncbi.nlm.nih.gov
Dear Editor, We read with interest the article by Sankhe et al. 1 on the role of Ayurcov (AyurCoro3), a one-day regimen as adjuvant therapy for COVID-19 disease management …
Introduction: In hospitalised mild to moderate COVID-19 patients with pre-existing type 2 diabetes, we evaluated the efficacy of add-on customised Ayurveda intervention as …